GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Shiller PE Ratio

MedMira (MedMira) Shiller PE Ratio : (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is MedMira Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedMira Shiller PE Ratio Historical Data

The historical data trend for MedMira's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Shiller PE Ratio Chart

MedMira Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedMira Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MedMira's Shiller PE Ratio

For the Biotechnology subindustry, MedMira's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMira's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MedMira's Shiller PE Ratio falls into.



MedMira Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MedMira's E10 for the quarter that ended in Jan. 2024 is calculated as:

For example, MedMira's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.001/125.0724*125.0724
=-0.001

Current CPI (Jan. 2024) = 125.0724.

MedMira Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201404 -0.002 98.920 -0.003
201407 0.000 99.315 0.000
201410 -0.002 99.473 -0.003
201501 -0.002 98.209 -0.003
201504 -0.002 99.710 -0.003
201507 -0.001 100.579 -0.001
201510 -0.001 100.500 -0.001
201601 -0.001 100.184 -0.001
201604 -0.001 101.370 -0.001
201607 -0.003 101.844 -0.004
201610 -0.001 102.002 -0.001
201701 -0.001 102.318 -0.001
201704 -0.001 103.029 -0.001
201707 -0.001 103.029 -0.001
201710 -0.001 103.424 -0.001
201801 -0.001 104.056 -0.001
201804 -0.001 105.320 -0.001
201807 -0.001 106.110 -0.001
201810 -0.001 105.952 -0.001
201901 -0.001 105.557 -0.001
201904 -0.001 107.453 -0.001
201907 0.000 108.243 0.000
201910 -0.001 107.927 -0.001
202001 -0.001 108.085 -0.001
202004 -0.001 107.216 -0.001
202007 0.000 108.401 0.000
202010 0.001 108.638 0.001
202101 0.000 109.192 0.000
202104 0.000 110.851 0.000
202107 -0.001 112.431 -0.001
202110 -0.001 113.695 -0.001
202201 -0.001 114.801 -0.001
202204 0.000 118.357 0.000
202207 -0.001 120.964 -0.001
202210 -0.001 121.517 -0.001
202301 -0.001 121.596 -0.001
202304 -0.001 123.571 -0.001
202307 -0.001 124.914 -0.001
202310 -0.001 125.310 -0.001
202401 -0.001 125.072 -0.001

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MedMira  (OTCPK:MMIRF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MedMira Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MedMira's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMira (MedMira) Business Description

Traded in Other Exchanges
Address
155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

MedMira (MedMira) Headlines

From GuruFocus

MedMira Receives CE Mark for Its VYRA(TM) COVID-19 Antigen Test

By ACCESSWIRE ACCESSWIRE 10-14-2022

Progress Update on MedMira's COVID-19 Product Family

By GlobeNewswire GlobeNewswire 01-30-2021

MedMira Reports FY2021 Fourth Quarter and Year End Financial Results

By GlobeNewswire GlobeNewswire 12-01-2021

MedMira Reports First Quarter Results FY2020

By GlobeNewswire GlobeNewswire 12-31-2019

MedMira Reports Third Quarter Results

By GlobeNewswire GlobeNewswire 06-30-2018

MedMira Reports Second Quarter Results

By GlobeNewswire GlobeNewswire 03-30-2018

Management Cease Trade Order Update

By GlobeNewswire GlobeNewswire 12-26-2018

Progress Update on Securities

By ACCESSWIRE 08-31-2023

MedMira Closes New Equity Investment for Future Growth

By GlobeNewswire GlobeNewswire 07-15-2021